why aren't all 6 resolved? a statement only gets an assessment when the public
record can support or contradict it. opinions and what-ifs never can, and 0 checkable
ones are still open, waiting for their date. predictions held up or didn't;
assertions are supported or contradicted. on every card:
▮▮▮▮▮ certainty ·
▮▮▮▮▮ debate potential. speakers are clickable
Assertion Supported
Dan Go: Ozempic Users Without Resistance Training Risk Osteoporosis and Severe Muscle Loss
“Like, I've seen people go on Ozempic and not eat high protein, not do resistance training, and then we're starting to see that people are coming up with osteoporosis. Starting to see people lose a shit ton of lean mass.”
Assertion Supported
Sanchez: Ozempic costs under $5 to make but sells for $1,000 monthly
“Well, Yale says that Ozempic costs less than five dollars a month to manufacture, And yet we're getting charged a thousand dollars a month for this drug. While the exact same product can be bought in Canada for a 155 dollars a month and 59 dollars a month in G…”
Assertion Partly supported
Israetel: Tirzepatide outperforms Ozempic, with more potent fifth-gen GLP drugs in trials
“Technically it's a third generation GLP drug, but fourth gen is Trisapatide. It's already on the market, Manjaro. Fewer side effects, bigger primary effect. There are fifth gen drugs currently in FDA approval process, which make Ozempic look like a starter pac…”
Assertion Partly supported
Dan Go: Hunger Remains Elevated for Three to Six Months After Stopping Ozempic
“The struggle bus period is like the three to even six months where your hunger is going to be elevated as a result of getting off of Ozempic.”
Assertion Supported
Israetel: GLP-1 drugs curb obesity primarily by lowering genetic food drive
“New medications like Ozempic, Trisapatide, et cetera, Manjaro, all those things. While, why they were some of the only things to really take a big chunk out of obesity is because they take your, whatever genetic food drive and palatability drive you have, how …”
Assertion Partly supported
Sanchez: Ozempic drove 41% of Novo Nordisk's record $13.9 billion profit
“Novo is having the highest record profits of all time, 13.9 billion dollars, and Ozempic alone accounted for like 41% of that, which makes it the fourth highest sold drug of all time.”